Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1259, 2000-01, pp. : 10-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
-Galactosidase replacement therapy in Fabry's disease
Inpharma, Vol. 1, Iss. 1303, 2001-01 ,pp. :
-Galactosidase appears to decrease cardiac mass and correct the metabolic defect of Fabry's disease
Inpharma, Vol. 1, Iss. 1292, 2001-01 ,pp. :
Fabry Disease and Cardiovascular Involvement
Current Pharmaceutical Design, Vol. 19, Iss. 33, 2013-10 ,pp. :